ID   TSP2_HUMAN              Reviewed;        1172 AA.
AC   P35442; A6H8N1; A7E232; Q5RI52;
DT   01-JUN-1994, integrated into UniProtKB/Swiss-Prot.
DT   25-NOV-2008, sequence version 2.
DT   22-JUL-2015, entry version 159.
DE   RecName: Full=Thrombospondin-2;
DE   Flags: Precursor;
GN   Name=THBS2; Synonyms=TSP2;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RX   PubMed=8406456; DOI=10.1006/geno.1993.1308;
RA   Labell T.L., Byers P.H.;
RT   "Sequence and characterization of the complete human thrombospondin 2
RT   cDNA: potential regulatory role for the 3' untranslated region.";
RL   Genomics 17:225-229(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Testis;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 560-1172.
RC   TISSUE=Fibroblast;
RX   PubMed=1559694; DOI=10.1016/0888-7543(92)90430-Z;
RA   Labell T.L., McGookey Milewicz D.J., Disteche C.M., Byers P.H.;
RT   "Thrombospondin II: partial cDNA sequence, chromosome location, and
RT   expression of a second member of the thrombospondin gene family in
RT   humans.";
RL   Genomics 12:421-429(1992).
RN   [7]
RP   INTERACTION WITH THBS1 AND THBS2.
RX   PubMed=1371676; DOI=10.1016/0006-291X(92)91860-S;
RA   Asch A.S., Silbiger S., Heimer E., Nachman R.L.;
RT   "Thrombospondin sequence motif (CSVTCG) is responsible for CD36
RT   binding.";
RL   Biochem. Biophys. Res. Commun. 182:1208-1217(1992).
RN   [8]
RP   DISULFIDE BONDS IN THROMBOSPONDIN DOMAIN.
RX   PubMed=11590138; DOI=10.1074/jbc.M104218200;
RA   Misenheimer T.M., Hahr A.J., Harms A.C., Annis D.S., Mosher D.F.;
RT   "Disulfide connectivity of recombinant C-terminal region of human
RT   thrombospondin 2.";
RL   J. Biol. Chem. 276:45882-45887(2001).
RN   [9]
RP   INVOLVEMENT IN SUSCEPTIBILITY TO IDD, AND TISSUE SPECIFICITY.
RX   PubMed=18455130; DOI=10.1016/j.ajhg.2008.03.013;
RA   Hirose Y., Chiba K., Karasugi T., Nakajima M., Kawaguchi Y.,
RA   Mikami Y., Furuichi T., Mio F., Miyake A., Miyamoto T., Ozaki K.,
RA   Takahashi A., Mizuta H., Kubo T., Kimura T., Tanaka T., Toyama Y.,
RA   Ikegawa S.;
RT   "A functional polymorphism in THBS2 that affects alternative splicing
RT   and MMP binding is associated with lumbar-disc herniation.";
RL   Am. J. Hum. Genet. 82:1122-1129(2008).
RN   [10]
RP   FUNCTION.
RX   PubMed=20714802; DOI=10.1007/s10549-010-1085-7;
RA   Koch M., Hussein F., Woeste A., Grundker C., Frontzek K., Emons G.,
RA   Hawighorst T.;
RT   "CD36-mediated activation of endothelial cell apoptosis by an N-
RT   terminal recombinant fragment of thrombospondin-2 inhibits breast
RT   cancer growth and metastasis in vivo.";
RL   Breast Cancer Res. Treat. 128:337-346(2011).
RN   [11]
RP   X-RAY CRYSTALLOGRAPHY (2.6 ANGSTROMS) OF 551-1172 IN COMPLEX WITH
RP   CALCIUM IONS, DISULFIDE BONDS, AND GLYCOSYLATION AT ASN-584; ASN-710
RP   AND ASN-1069.
RX   PubMed=16186819; DOI=10.1038/nsmb997;
RA   Carlson C.B., Bernstein D.A., Annis D.S., Misenheimer T.M.,
RA   Hannah B.L., Mosher D.F., Keck J.L.;
RT   "Structure of the calcium-rich signature domain of human
RT   thrombospondin-2.";
RL   Nat. Struct. Mol. Biol. 12:910-914(2005).
RN   [12]
RP   X-RAY CRYSTALLOGRAPHY (2.9 ANGSTROMS) OF 551-1172, AND MUTAGENESIS OF
RP   ASN-702.
RX   PubMed=18499674; DOI=10.1074/jbc.M800223200;
RA   Carlson C.B., Liu Y., Keck J.L., Mosher D.F.;
RT   "Influences of the N700S thrombospondin-1 polymorphism on protein
RT   structure and stability.";
RL   J. Biol. Chem. 283:20069-20076(2008).
CC   -!- FUNCTION: Adhesive glycoprotein that mediates cell-to-cell and
CC       cell-to-matrix interactions. Ligand for CD36 mediating
CC       antiangiogenic properties. {ECO:0000269|PubMed:20714802}.
CC   -!- SUBUNIT: Homotrimer; disulfide-linked. Interacts (via the TSP type
CC       I repeats) with CD36; the interaction conveys an antiangiogenic
CC       effect. Interacts (via the TSP type I repeats) with HRG; the
CC       interaction blocks the antiangiogenic effect of THBS2 with CD36
CC       (By similarity). Can bind to fibrinogen, fibronectin, laminin and
CC       type V collagen. {ECO:0000250, ECO:0000269|PubMed:11590138,
CC       ECO:0000269|PubMed:1371676, ECO:0000269|PubMed:16186819}.
CC   -!- INTERACTION:
CC       P54290:Cacna2d1 (xeno); NbExp=2; IntAct=EBI-2466249, EBI-2466294;
CC   -!- TISSUE SPECIFICITY: High expression in invertebral disk tissue.
CC       {ECO:0000269|PubMed:18455130}.
CC   -!- DISEASE: Intervertebral disc disease (IDD) [MIM:603932]: A common
CC       musculo-skeletal disorder caused by degeneration of intervertebral
CC       disks of the lumbar spine. It results in low-back pain and
CC       unilateral leg pain. {ECO:0000269|PubMed:18455130}. Note=Disease
CC       susceptibility is associated with variations affecting the gene
CC       represented in this entry.
CC   -!- SIMILARITY: Belongs to the thrombospondin family. {ECO:0000305}.
CC   -!- SIMILARITY: Contains 2 EGF-like domains. {ECO:0000255|PROSITE-
CC       ProRule:PRU00076}.
CC   -!- SIMILARITY: Contains 1 laminin G-like domain. {ECO:0000305}.
CC   -!- SIMILARITY: Contains 1 TSP C-terminal (TSPC) domain.
CC       {ECO:0000255|PROSITE-ProRule:PRU00635}.
CC   -!- SIMILARITY: Contains 3 TSP type-1 domains. {ECO:0000255|PROSITE-
CC       ProRule:PRU00210}.
CC   -!- SIMILARITY: Contains 8 TSP type-3 repeats. {ECO:0000255|PROSITE-
CC       ProRule:PRU00634}.
CC   -!- SIMILARITY: Contains 1 VWFC domain. {ECO:0000255|PROSITE-
CC       ProRule:PRU00220}.
CC   -!- WEB RESOURCE: Name=Atlas of Genetics and Cytogenetics in Oncology
CC       and Haematology;
CC       URL="http://atlasgeneticsoncology.org/Genes/THBS2ID42549ch6q27.html";
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L12350; AAA03703.1; -; mRNA.
DR   EMBL; M81339; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AK292429; BAF85118.1; -; mRNA.
DR   EMBL; BX322234; CAI23645.1; -; Genomic_DNA.
DR   EMBL; CH471051; EAW47455.1; -; Genomic_DNA.
DR   EMBL; BC146676; AAI46677.1; -; mRNA.
DR   EMBL; BC150175; AAI50176.1; -; mRNA.
DR   CCDS; CCDS34574.1; -.
DR   PIR; A47379; TSHUP2.
DR   RefSeq; NP_003238.2; NM_003247.3.
DR   UniGene; Hs.371147; -.
DR   PDB; 1YO8; X-ray; 2.60 A; A=551-1172.
DR   PDB; 2RHP; X-ray; 2.90 A; A=551-1172.
DR   PDBsum; 1YO8; -.
DR   PDBsum; 2RHP; -.
DR   ProteinModelPortal; P35442; -.
DR   SMR; P35442; 25-226, 383-492, 494-1172.
DR   BioGrid; 112916; 2.
DR   IntAct; P35442; 1.
DR   STRING; 9606.ENSP00000355751; -.
DR   PhosphoSite; P35442; -.
DR   BioMuta; THBS2; -.
DR   DMDM; 215273908; -.
DR   MaxQB; P35442; -.
DR   PaxDb; P35442; -.
DR   PRIDE; P35442; -.
DR   Ensembl; ENST00000366787; ENSP00000355751; ENSG00000186340.
DR   Ensembl; ENST00000617924; ENSP00000482784; ENSG00000186340.
DR   GeneID; 7058; -.
DR   KEGG; hsa:7058; -.
DR   UCSC; uc003qwt.3; human.
DR   CTD; 7058; -.
DR   GeneCards; GC06M169615; -.
DR   H-InvDB; HIX0025092; -.
DR   H-InvDB; HIX0165050; -.
DR   HGNC; HGNC:11786; THBS2.
DR   HPA; CAB017716; -.
DR   HPA; HPA044304; -.
DR   MIM; 188061; gene.
DR   MIM; 603932; phenotype.
DR   neXtProt; NX_P35442; -.
DR   PharmGKB; PA36498; -.
DR   eggNOG; NOG12793; -.
DR   GeneTree; ENSGT00800000124017; -.
DR   HOGENOM; HOG000007542; -.
DR   HOVERGEN; HBG018006; -.
DR   InParanoid; P35442; -.
DR   KO; K04659; -.
DR   OMA; TEKQVCE; -.
DR   OrthoDB; EOG76QFGD; -.
DR   PhylomeDB; P35442; -.
DR   TreeFam; TF324917; -.
DR   Reactome; REACT_16888; Signaling by PDGF.
DR   Reactome; REACT_264269; O-glycosylation of TSR domain-containing proteins.
DR   ChiTaRS; THBS2; human.
DR   EvolutionaryTrace; P35442; -.
DR   GeneWiki; THBS2; -.
DR   GenomeRNAi; 7058; -.
DR   NextBio; 27601; -.
DR   PMAP-CutDB; Q5RI52; -.
DR   PRO; PR:P35442; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; P35442; -.
DR   CleanEx; HS_THBS2; -.
DR   ExpressionAtlas; P35442; baseline and differential.
DR   Genevisible; P35442; HS.
DR   GO; GO:0005604; C:basement membrane; IEA:Ensembl.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0031091; C:platelet alpha granule; IDA:UniProtKB.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0008201; F:heparin binding; TAS:ProtInc.
DR   GO; GO:0007155; P:cell adhesion; IEA:UniProtKB-KW.
DR   GO; GO:0016525; P:negative regulation of angiogenesis; IDA:UniProtKB.
DR   GO; GO:0051965; P:positive regulation of synapse assembly; IEA:Ensembl.
DR   Gene3D; 2.60.120.200; -; 3.
DR   Gene3D; 4.10.1080.10; -; 2.
DR   InterPro; IPR013320; ConA-like_dom.
DR   InterPro; IPR000742; EG-like_dom.
DR   InterPro; IPR001881; EGF-like_Ca-bd_dom.
DR   InterPro; IPR013032; EGF-like_CS.
DR   InterPro; IPR024731; EGF_dom_MSP1-like.
DR   InterPro; IPR001791; Laminin_G.
DR   InterPro; IPR015455; Thrombospondin-2.
DR   InterPro; IPR000884; Thrombospondin_1_rpt.
DR   InterPro; IPR003367; Thrombospondin_3-like_rpt.
DR   InterPro; IPR017897; Thrombospondin_3_rpt.
DR   InterPro; IPR008859; Thrombospondin_C.
DR   InterPro; IPR028974; TSP_type-3_rpt.
DR   InterPro; IPR001007; VWF_C.
DR   PANTHER; PTHR10199:SF10; PTHR10199:SF10; 1.
DR   Pfam; PF12947; EGF_3; 1.
DR   Pfam; PF07645; EGF_CA; 1.
DR   Pfam; PF00090; TSP_1; 3.
DR   Pfam; PF02412; TSP_3; 7.
DR   Pfam; PF05735; TSP_C; 1.
DR   Pfam; PF00093; VWC; 1.
DR   SMART; SM00181; EGF; 3.
DR   SMART; SM00209; TSP1; 3.
DR   SMART; SM00210; TSPN; 1.
DR   SMART; SM00214; VWC; 1.
DR   SUPFAM; SSF103647; SSF103647; 3.
DR   SUPFAM; SSF49899; SSF49899; 2.
DR   SUPFAM; SSF82895; SSF82895; 3.
DR   PROSITE; PS01186; EGF_2; 1.
DR   PROSITE; PS50026; EGF_3; 2.
DR   PROSITE; PS50092; TSP1; 3.
DR   PROSITE; PS51234; TSP3; 8.
DR   PROSITE; PS51236; TSP_CTER; 1.
DR   PROSITE; PS01208; VWFC_1; 1.
DR   PROSITE; PS50184; VWFC_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Calcium; Cell adhesion; Complete proteome;
KW   Disulfide bond; EGF-like domain; Glycoprotein; Heparin-binding;
KW   Polymorphism; Reference proteome; Repeat; Signal.
FT   SIGNAL        1     18       {ECO:0000255}.
FT   CHAIN        19   1172       Thrombospondin-2.
FT                                /FTId=PRO_0000035846.
FT   DOMAIN       19    215       Laminin G-like.
FT   DOMAIN      318    375       VWFC. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00220}.
FT   DOMAIN      381    431       TSP type-1 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00210}.
FT   DOMAIN      437    492       TSP type-1 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00210}.
FT   DOMAIN      494    549       TSP type-1 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00210}.
FT   DOMAIN      549    589       EGF-like 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   DOMAIN      648    692       EGF-like 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00076}.
FT   REPEAT      693    728       TSP type-3 1.
FT   REPEAT      729    764       TSP type-3 2.
FT   REPEAT      765    787       TSP type-3 3.
FT   REPEAT      788    823       TSP type-3 4.
FT   REPEAT      824    846       TSP type-3 5.
FT   REPEAT      847    884       TSP type-3 6.
FT   REPEAT      885    920       TSP type-3 7.
FT   REPEAT      921    956       TSP type-3 8.
FT   DOMAIN      960   1172       TSP C-terminal. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00635}.
FT   REGION       19    232       Heparin-binding. {ECO:0000255}.
FT   MOTIF       928    930       Cell attachment site. {ECO:0000255}.
FT   CARBOHYD    151    151       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    316    316       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    330    330       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    457    457       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    584    584       N-linked (GlcNAc...).
FT                                {ECO:0000269|PubMed:16186819}.
FT   CARBOHYD    710    710       N-linked (GlcNAc...).
FT                                {ECO:0000269|PubMed:16186819}.
FT   CARBOHYD   1069   1069       N-linked (GlcNAc...).
FT                                {ECO:0000269|PubMed:16186819}.
FT   DISULFID    266    266       Interchain. {ECO:0000305}.
FT   DISULFID    270    270       Interchain. {ECO:0000305}.
FT   DISULFID    393    425       {ECO:0000250}.
FT   DISULFID    397    430       {ECO:0000250}.
FT   DISULFID    408    415       {ECO:0000250}.
FT   DISULFID    449    486       {ECO:0000250}.
FT   DISULFID    453    491       {ECO:0000250}.
FT   DISULFID    464    476       {ECO:0000250}.
FT   DISULFID    506    543       {ECO:0000250}.
FT   DISULFID    510    548       {ECO:0000250}.
FT   DISULFID    521    533       {ECO:0000250}.
FT   DISULFID    553    564
FT   DISULFID    558    574
FT   DISULFID    577    588
FT   DISULFID    594    610
FT   DISULFID    601    619
FT   DISULFID    622    646
FT   DISULFID    652    665
FT   DISULFID    659    678
FT   DISULFID    680    691
FT   DISULFID    707    715
FT   DISULFID    720    740
FT   DISULFID    756    776
FT   DISULFID    779    799
FT   DISULFID    815    835
FT   DISULFID    838    858
FT   DISULFID    876    896
FT   DISULFID    912    932
FT   DISULFID    948   1169
FT   VARIANT     133    133       T -> S (in dbSNP:rs36088849).
FT                                /FTId=VAR_045842.
FT   VARIANT     375    375       L -> F (in dbSNP:rs35404985).
FT                                /FTId=VAR_045843.
FT   MUTAGEN     702    702       N->S: Alters protein stability.
FT                                {ECO:0000269|PubMed:18499674}.
FT   CONFLICT      2      2       V -> A (in Ref. 5; AAI50176).
FT                                {ECO:0000305}.
FT   CONFLICT    171    173       DSF -> GPV (in Ref. 1; AAA03703).
FT                                {ECO:0000305}.
FT   CONFLICT    576    576       S -> F (in Ref. 1; AAA03703).
FT                                {ECO:0000305}.
FT   CONFLICT   1111   1111       R -> G (in Ref. 5; AAI46677).
FT                                {ECO:0000305}.
FT   HELIX       552    555       {ECO:0000244|PDB:1YO8}.
FT   STRAND      564    566       {ECO:0000244|PDB:1YO8}.
FT   STRAND      572    574       {ECO:0000244|PDB:1YO8}.
FT   STRAND      585    587       {ECO:0000244|PDB:1YO8}.
FT   TURN        593    596       {ECO:0000244|PDB:1YO8}.
FT   STRAND      605    607       {ECO:0000244|PDB:1YO8}.
FT   STRAND      610    612       {ECO:0000244|PDB:1YO8}.
FT   STRAND      614    619       {ECO:0000244|PDB:1YO8}.
FT   STRAND      626    628       {ECO:0000244|PDB:1YO8}.
FT   STRAND      632    636       {ECO:0000244|PDB:1YO8}.
FT   HELIX       637    640       {ECO:0000244|PDB:1YO8}.
FT   STRAND      646    648       {ECO:0000244|PDB:1YO8}.
FT   TURN        651    655       {ECO:0000244|PDB:1YO8}.
FT   STRAND      663    667       {ECO:0000244|PDB:1YO8}.
FT   STRAND      673    680       {ECO:0000244|PDB:1YO8}.
FT   STRAND      684    693       {ECO:0000244|PDB:1YO8}.
FT   STRAND      697    700       {ECO:0000244|PDB:1YO8}.
FT   TURN        706    710       {ECO:0000244|PDB:1YO8}.
FT   STRAND      712    714       {ECO:0000244|PDB:1YO8}.
FT   STRAND      734    736       {ECO:0000244|PDB:1YO8}.
FT   TURN        738    740       {ECO:0000244|PDB:1YO8}.
FT   STRAND      746    749       {ECO:0000244|PDB:1YO8}.
FT   TURN        751    753       {ECO:0000244|PDB:1YO8}.
FT   TURN        755    758       {ECO:0000244|PDB:2RHP}.
FT   STRAND      767    772       {ECO:0000244|PDB:1YO8}.
FT   HELIX       774    776       {ECO:0000244|PDB:1YO8}.
FT   STRAND      793    795       {ECO:0000244|PDB:1YO8}.
FT   HELIX       797    799       {ECO:0000244|PDB:1YO8}.
FT   STRAND      805    808       {ECO:0000244|PDB:1YO8}.
FT   TURN        810    812       {ECO:0000244|PDB:1YO8}.
FT   STRAND      829    831       {ECO:0000244|PDB:1YO8}.
FT   HELIX       833    835       {ECO:0000244|PDB:1YO8}.
FT   STRAND      851    854       {ECO:0000244|PDB:1YO8}.
FT   TURN        856    858       {ECO:0000244|PDB:1YO8}.
FT   STRAND      866    869       {ECO:0000244|PDB:1YO8}.
FT   HELIX       871    873       {ECO:0000244|PDB:1YO8}.
FT   STRAND      890    892       {ECO:0000244|PDB:1YO8}.
FT   TURN        894    896       {ECO:0000244|PDB:1YO8}.
FT   STRAND      903    905       {ECO:0000244|PDB:1YO8}.
FT   HELIX       907    909       {ECO:0000244|PDB:1YO8}.
FT   TURN        911    914       {ECO:0000244|PDB:1YO8}.
FT   STRAND      926    928       {ECO:0000244|PDB:1YO8}.
FT   HELIX       930    932       {ECO:0000244|PDB:1YO8}.
FT   STRAND      939    941       {ECO:0000244|PDB:1YO8}.
FT   HELIX       943    945       {ECO:0000244|PDB:1YO8}.
FT   STRAND      960    968       {ECO:0000244|PDB:1YO8}.
FT   STRAND      971    973       {ECO:0000244|PDB:1YO8}.
FT   STRAND      979    982       {ECO:0000244|PDB:1YO8}.
FT   HELIX       983    985       {ECO:0000244|PDB:1YO8}.
FT   STRAND      987    990       {ECO:0000244|PDB:1YO8}.
FT   STRAND      995   1016       {ECO:0000244|PDB:1YO8}.
FT   STRAND     1024   1033       {ECO:0000244|PDB:1YO8}.
FT   STRAND     1036   1045       {ECO:0000244|PDB:1YO8}.
FT   STRAND     1053   1055       {ECO:0000244|PDB:1YO8}.
FT   STRAND     1061   1069       {ECO:0000244|PDB:1YO8}.
FT   HELIX      1076   1083       {ECO:0000244|PDB:1YO8}.
FT   STRAND     1084   1086       {ECO:0000244|PDB:1YO8}.
FT   TURN       1089   1091       {ECO:0000244|PDB:1YO8}.
FT   STRAND     1092   1097       {ECO:0000244|PDB:1YO8}.
FT   STRAND     1110   1116       {ECO:0000244|PDB:1YO8}.
FT   TURN       1118   1120       {ECO:0000244|PDB:1YO8}.
FT   STRAND     1122   1129       {ECO:0000244|PDB:1YO8}.
FT   STRAND     1132   1136       {ECO:0000244|PDB:1YO8}.
FT   STRAND     1139   1141       {ECO:0000244|PDB:2RHP}.
FT   STRAND     1148   1156       {ECO:0000244|PDB:1YO8}.
FT   STRAND     1159   1169       {ECO:0000244|PDB:1YO8}.
SQ   SEQUENCE   1172 AA;  129991 MW;  415BF376F4669F6A CRC64;
     MVWRLVLLAL WVWPSTQAGH QDKDTTFDLF SISNINRKTI GAKQFRGPDP GVPAYRFVRF
     DYIPPVNADD LSKITKIMRQ KEGFFLTAQL KQDGKSRGTL LALEGPGLSQ RQFEIVSNGP
     ADTLDLTYWI DGTRHVVSLE DVGLADSQWK NVTVQVAGET YSLHVGCDLI DSFALDEPFY
     EHLQAEKSRM YVAKGSARES HFRGLLQNVH LVFENSVEDI LSKKGCQQGQ GAEINAISEN
     TETLRLGPHV TTEYVGPSSE RRPEVCERSC EELGNMVQEL SGLHVLVNQL SENLKRVSND
     NQFLWELIGG PPKTRNMSAC WQDGRFFAEN ETWVVDSCTT CTCKKFKTIC HQITCPPATC
     ASPSFVEGEC CPSCLHSVDG EEGWSPWAEW TQCSVTCGSG TQQRGRSCDV TSNTCLGPSI
     QTRACSLSKC DTRIRQDGGW SHWSPWSSCS VTCGVGNITR IRLCNSPVPQ MGGKNCKGSG
     RETKACQGAP CPIDGRWSPW SPWSACTVTC AGGIRERTRV CNSPEPQYGG KACVGDVQER
     QMCNKRSCPV DGCLSNPCFP GAQCSSFPDG SWSCGSCPVG FLGNGTHCED LDECALVPDI
     CFSTSKVPRC VNTQPGFHCL PCPPRYRGNQ PVGVGLEAAK TEKQVCEPEN PCKDKTHNCH
     KHAECIYLGH FSDPMYKCEC QTGYAGDGLI CGEDSDLDGW PNLNLVCATN ATYHCIKDNC
     PHLPNSGQED FDKDGIGDAC DDDDDNDGVT DEKDNCQLLF NPRQADYDKD EVGDRCDNCP
     YVHNPAQIDT DNNGEGDACS VDIDGDDVFN ERDNCPYVYN TDQRDTDGDG VGDHCDNCPL
     VHNPDQTDVD NDLVGDQCDN NEDIDDDGHQ NNQDNCPYIS NANQADHDRD GQGDACDPDD
     DNDGVPDDRD NCRLVFNPDQ EDLDGDGRGD ICKDDFDNDN IPDIDDVCPE NNAISETDFR
     NFQMVPLDPK GTTQIDPNWV IRHQGKELVQ TANSDPGIAV GFDEFGSVDF SGTFYVNTDR
     DDDYAGFVFG YQSSSRFYVV MWKQVTQTYW EDQPTRAYGY SGVSLKVVNS TTGTGEHLRN
     ALWHTGNTPG QVRTLWHDPR NIGWKDYTAY RWHLTHRPKT GYIRVLVHEG KQVMADSGPI
     YDQTYAGGRL GLFVFSQEMV YFSDLKYECR DI
//
